Jenny Shum

Delman Lebel

Head Of US Corporate Affairs

Yvonne Armstrong

Director Of Communications, Alexion Astrazeneca Rare Disease

Alyssa Bendyk

Head Of HR Rare Disease Business Unit, US Business

Phil Milam

Senior Director, Access And Reimbursement US (rare Disease)

Matt Hay

U.s. Director Of Advocacy For Metabolics - Neurofibromatosis (nf) And Hypophosphatasia (hpp)

Christina Aberer

Rare Disease Partner Switzerland

Elizabeth Hackbarth

Director Patient Advocacy

Jonathan Monteleone

Executive Director, CPSS At Alexion, Astrazeneca Rare Disease